I'm really hopeful though about the genetic revolution that's happening though, I just wish it was happening faster (my girlfriend just got diagnosed with cancer again today :( )
And no, they didn’t create an injectable drug because it’s “popular”. They did it because it address compliance of oral therapies.
That's good to know and something I've been curious about. Do you have a source that breaks down the other 90%?
The best analysis I've found so far is from McKinsey.[1] They took a very clever approach to benchmark US healthcare spending to other OECD countries. They adjusted for US GDP (richer countries spend more on healthcare), then broke down costs by category and figured out how much more/less the US spent compared to OECD countries. Very eye opening if you check out the graph at the bottom of page 4.
Findings: 1) out-patient care is driving ~70% of the extra cost, 2) in-patient costs are ~10% higher than OECD, 3) the US spend 50% more on drugs, but it's a small part of overall spending, 4) administration is 200% higher, but again, it doesn't add up to that much, 5) the US spends less on long-term and home care and 6) the US invests 50% more in healthcare, but it's not a large absolute amount.
[1]https://www.mckinsey.com/~/media/mckinsey/dotcom/client_serv...